661 related articles for article (PubMed ID: 8875226)
21. [Packaging and concentrating of high titer of retrovirus containing IL-4RA].
Wang GL; Liu XT; Lu JR
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):761-4. PubMed ID: 19755029
[TBL] [Abstract][Full Text] [Related]
22. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS
J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069
[TBL] [Abstract][Full Text] [Related]
23. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
[TBL] [Abstract][Full Text] [Related]
24. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.
Li KQ; Li WL; Peng SY; Shi XY; Tang HL; Liu YB
Chin Med J (Engl); 2004 Sep; 117(9):1364-9. PubMed ID: 15377430
[TBL] [Abstract][Full Text] [Related]
26. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
[TBL] [Abstract][Full Text] [Related]
27. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair.
Mason JM; Grande DA; Barcia M; Grant R; Pergolizzi RG; Breitbart AS
Gene Ther; 1998 Aug; 5(8):1098-104. PubMed ID: 10326033
[TBL] [Abstract][Full Text] [Related]
28. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
Shiau AL; Lin CY; Tzai TS; Wu CL
Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
[TBL] [Abstract][Full Text] [Related]
29. Characterization of transient expression system for retroviral vector production.
Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
[TBL] [Abstract][Full Text] [Related]
30. Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors.
Hlavaty J; Portsmouth D; Stracke A; Salmons B; Günzburg WH; Renner M
Virology; 2004 Dec; 330(1):351-60. PubMed ID: 15527860
[TBL] [Abstract][Full Text] [Related]
31. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.
Coroadinha AS; Schucht R; Gama-Norton L; Wirth D; Hauser H; Carrondo MJ
J Biotechnol; 2006 Jul; 124(2):457-68. PubMed ID: 16529836
[TBL] [Abstract][Full Text] [Related]
32. Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes.
Parolin C; Taddeo B; Palú G; Sodroski J
Virology; 1996 Aug; 222(2):415-22. PubMed ID: 8806525
[TBL] [Abstract][Full Text] [Related]
33. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
[TBL] [Abstract][Full Text] [Related]
34. Exogenous peptide and protein expression levels using retroviral vectors in human cells.
Sandrock TM; Risley B; Richards BT; Poritz MA; Austin HA; Yoo S; Kim MK; Roth B; Repetny K; Hsu F; Stump M; Teng DH; Kamb A
Mol Ther; 2001 Nov; 4(5):398-406. PubMed ID: 11708876
[TBL] [Abstract][Full Text] [Related]
35. Effect of cellular type on expression of acid beta-glucosidase: implications for gene therapy in Gaucher disease.
Xu YH; Wenstrup R; Grabowski GA
Gene Ther; 1995 Nov; 2(9):647-54. PubMed ID: 8548554
[TBL] [Abstract][Full Text] [Related]
36. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
37. Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector.
Lee JT; Yu SS; Han E; Kim S; Kim S
Gene Ther; 2004 Jan; 11(1):94-9. PubMed ID: 14681702
[TBL] [Abstract][Full Text] [Related]
38. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
[TBL] [Abstract][Full Text] [Related]
39. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats.
Makarov SS; Olsen JC; Johnston WN; Schwab JH; Anderle SK; Brown RR; Haskill JS
Gene Ther; 1995 Aug; 2(6):424-8. PubMed ID: 7584118
[TBL] [Abstract][Full Text] [Related]
40. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]